Clinical Trial Update: A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD) [Phase 2]

View source ↗

Summary

Phase 2 trial of Epizon-701 (EPN-701) in subjects with end-stage renal disease has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Epizon-701 (EPN-701)

Snippet

Sponsor: Epizon Pharma, Inc. | Conditions: End-Stage Renal Disease (ESRD) | Phase 2 | Status: COMPLETED | Results posted: 2024-09-25